Header Logo

Connection

NATALIA LAPTEVA to Lymphocytes

Back to Details
This is a "connection" page, showing publications NATALIA LAPTEVA has written about Lymphocytes.
NATALIA LAPTEVA
Connection Strength
0.047
Lymphocytes
  1. Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients. Haematologica. 2023 Jul 01; 108(7):1840-1850.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.